Nivolumab-induced thyroid dysfunction in patients with lung cancer. [electronic resource]
Producer: 20190912Description: 26-34 p. digitalISSN:- 2530-0180
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Immunological -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Nivolumab -- adverse effects
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Thyroid Diseases -- chemically induced
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.